| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.041 | 0.4 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.4 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.4 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.041 | 0.4 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.041 | 0.4 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.042 | 0.4 |